EDESA BIOTECH, INC. Business Combination, Consideration Transferred, Equity Interests Issued and Issuable
EDESA BIOTECH, INC. (EDSA) reported Business Combination, Consideration Transferred, Equity Interests Issued and Issuable of $4.63 million for the 12-month period ending 2020-09-30, per its 10-K filed 2020-12-07.
Discontinued › Notes › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation › Business Combination, Consideration Transferred
us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable · last filed 2020-12-07
- EDESA BIOTECH, INC. business combination, consideration transferred, equity interests issued and issuable for the quarter ending 2019-09-30 was $0.00.
- EDESA BIOTECH, INC. business combination, consideration transferred, equity interests issued and issuable for fiscal 2020 was $4.63M.
| Period end | Business Combination, Consideration Transferred, Equity Interests Issued and Issuable 3 month | Business Combination, Consideration Transferred, Equity Interests Issued and Issuable 6 month | Business Combination, Consideration Transferred, Equity Interests Issued and Issuable 9 month | Business Combination, Consideration Transferred, Equity Interests Issued and Issuable 12 month |
|---|---|---|---|---|
| 2020-09-30 | $4.63M 10-K · filed 2020-12-07 | |||
| 2019-09-30 | $0.00 derived: 10-KT 9 month − 10-Q 6 month · filed 2019-12-12 | $4.63M 10-KT · filed 2019-12-12 | ||
| 2019-06-30 | $4.63M 10-Q · filed 2019-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |